Krilogy Financial LLC Invests $336,000 in DENTSPLY SIRONA Inc. $XRAY

Key Points

• Krilogy Financial LLC acquired a new stake in DENTSPLY SIRONA Inc., purchasing 21,169 shares valued at approximately $336,000.
• Wall Street analysts have been cutting their target prices for DENTSPLY SIRONA, with a consensus target price now at $18.64 and a majority rating of "Hold".
• The company announced a quarterly dividend of $0.16 per share, with a yield of 4.7%, scheduled for payment on October 10th.

Krilogy Financial LLC acquired a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 21,169 shares of the medical instruments supplier's stock, valued at approximately $336,000.

Other hedge funds have also added to or reduced their stakes in the company. Gabelli Funds LLC lifted its position in shares of DENTSPLY SIRONA by 1.0% during the 1st quarter. Gabelli Funds LLC now owns 98,000 shares of the medical instruments supplier's stock valued at $1,464,000 after buying an additional 1,000 shares during the last quarter. Empowered Funds LLC lifted its holdings in DENTSPLY SIRONA by 8.8% during the first quarter. Empowered Funds LLC now owns 16,324 shares of the medical instruments supplier's stock valued at $244,000 after purchasing an additional 1,320 shares during the last quarter. Covestor Ltd boosted its position in DENTSPLY SIRONA by 17.5% during the first quarter. Covestor Ltd now owns 9,778 shares of the medical instruments supplier's stock worth $146,000 after purchasing an additional 1,456 shares during the period. Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of DENTSPLY SIRONA in the first quarter valued at approximately $25,000. Finally, Principal Financial Group Inc. lifted its stake in shares of DENTSPLY SIRONA by 0.4% during the 1st quarter. Principal Financial Group Inc. now owns 457,397 shares of the medical instruments supplier's stock valued at $6,834,000 after buying an additional 1,708 shares in the last quarter. Institutional investors own 95.70% of the company's stock.

Wall Street Analyst Weigh In

XRAY has been the subject of a number of recent research reports. Wall Street Zen lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Barrington Research lowered their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating on the stock in a research note on Friday, August 8th. Stifel Nicolaus dropped their target price on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating for the company in a research report on Friday, August 8th. UBS Group dropped their target price on shares of DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating for the company in a research report on Friday, August 8th. Finally, Wells Fargo & Company dropped their target price on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating for the company in a research report on Friday, August 8th. Two investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to data from MarketBeat, DENTSPLY SIRONA has an average rating of "Hold" and an average target price of $18.64.

DENTSPLY SIRONA Stock Down 1.9%

NASDAQ:XRAY traded down $0.26 on Friday, reaching $13.16. 6,019,803 shares of the stock traded hands, compared to its average volume of 3,002,555. The company has a market capitalization of $2.63 billion, a price-to-earnings ratio of -2.78, a PEG ratio of 0.84 and a beta of 0.96. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13. DENTSPLY SIRONA Inc. has a 12 month low of $12.16 and a 12 month high of $27.44. The company's fifty day simple moving average is $14.50 and its 200 day simple moving average is $14.94.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.50 by $0.02. The firm had revenue of $936.00 million for the quarter, compared to the consensus estimate of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The business's quarterly revenue was down 4.9% compared to the same quarter last year. During the same quarter last year, the firm posted $0.49 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Equities analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 10th. Investors of record on Friday, September 26th will be given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 4.9%. The ex-dividend date is Friday, September 26th. DENTSPLY SIRONA's dividend payout ratio is -13.50%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.